Topiramate, also sold under the brand name Topamax, is a drug approved by the U.S. Food and Drug Administration (FDA) for ...

It comprised children with intractable epilepsy who had received a mean of eight antiepileptic drugs and in whom topiramate was added to a median of two antiepileptic drugs. Clinical follow-up ...

OBJECTIVE: To examine the safety and effectiveness of topiramate as add-on therapy for the management of combat-related PTSD and to examine the effects of topiramate on sleep and alcohol consumption.

Weight-loss drugs can be life-changing for people who have struggled to lose weight, however, some people who take them experience unpleasant and concerning side effects. In 2024, roughly 5 per ...

Kennedy Jr. spoke with CBS News chief medical correspondent Dr. Jon LaPook about a range of topics, including measles, food additives and weight loss drugs. Here are some highlights from their ...

Senator John Fetterman admitted to using weight loss drug Mounjaro and has issued a plea about the 'game changer' medication. Fetterman, a democrat from Pennsylvania, said this week that he ...

Attorney General Pam Bondi said the Trump administration dealt a “major blow” to two Mexican drug cartels following the Coast Guard’s seizure of half a billion dollars’ worth of illicit ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

Notably, though, people’s desires for these foods didn’t completely go away. Ozempic and similar drugs mimic the natural GLP-1 hormone, which helps regulate our hunger and metabolism.

This was a mistake. These drugs, like Ozempic and Wegovy, can be a game changer. I know firsthand. In July, I was prescribed a drug called Mounjaro. As a stroke survivor, I was interested in ...

The CIA is reviewing its authorities to use lethal force against drug cartels in Mexico and beyond as the Trump administration moves to make taking on the cartels a major priority for the ...

The US Centers for Medicare & Medicaid Services (CMS) confirmed that it will not proceed with a Biden administration proposal to expand Medicare coverage for anti-obesity drugs such as Novo ...